Search Results 1571-1580 of 16874 for monoclonal antibody

  1. A Study of CDX-1127 (Varlilumab) in Patients with Select Solid Tumor Types or Hematologic Cancers - Mayo Clinic

    ... Antibody, in Patients With Advanced Solid Tumors. Burris HA. Howard A; Infante JR. Jeffrey R; Ansell SM. Stephen M; Nemunaitis JJ. John J; Weiss GR ...

  2. A Randomized Phase 2 Study of Combination Atezolizumab and CDX-1127 (Varlilumab) With or Without Addition of Cobimetinib in Previously Treated Unresectable Biliary Tract Cancers - Mayo Clinic

    [antibody to hepatitis B core antigen] antibody test) are eligible. - Patients positive for hepatitis C virus (HCV) antibody are eligible only if polymerase ...

  3. A Study to Evaluate Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Patients - Mayo Clinic

    Must be EITHER John Cunningham (JC) virus antibody negative or low positive (index antibody titer <0.9), OR negative for: Hepatitis B and C, tuberculosis.

  4. A Study to Evaluate UV1 Vaccination Plus Nivolumab and Ipilimumab in Treatment of Melanoma - Mayo Clinic

    ... antibodies). No HIV testing ... History of or active hepatitis B (hepatitis B surface antigen reactive) or active hepatitis C (hepatitis C virus antibody).

  5. Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024) - Mayo Clinic

    ... antibody (including ipilimumab or any other antibody or drug specifically targeting T-cell co-stimulation or checkpoint pathways); Has untreated central ...

  6. A Study to Evaluate eFT508 Alone and in Combination With Avelumab in Subjects With MSS Colorectal Cancer - Mayo Clinic

    Prior therapy with any of the following: PD-1, PD-L1, CTLA4 antibody, or any other drug targeting T cell checkpoint pathways. ... antibodies or infused ...

  7. Autoimmune epilepsy - Care at Mayo Clinic

    Mayo Clinic Laboratories was one of the first centers to offer an autoimmune encephalitis panel to check for antibodies and test for autoimmune epilepsy.

  8. Collaborative programs - Center for Multiple Sclerosis and Autoimmune Neurology - Mayo Clinic Research

    ... autoantibody profiles. The lab seeks to define neuronal muscle and glial antigens and investigates immunopathological mechanisms of neurological disease ...

  9. Advances in lung cancer immunotherapy and management of immune-mediated adverse events - Mayo Clinic

    Monotherapy, using the anti-PD-1 antibody pembrolizumab, is now Food and Drug Administration (FDA) approved for patients with stage IV non-small cell lung ...

  10. Publications - Paul J. Kurtin, M.D. - Mayo Clinic

    Hematologic characteristics of proliferative glomerulonephritides with nonorganized monoclonal immunoglobulin deposits. Mayo Clin Proc. 2015 May; 90 (5):587 ...